Share Price and Basic Stock Data
Last Updated: January 17, 2026, 6:28 am
| PEG Ratio | 0.90 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Banco Products (India) Ltd operates in the auto ancillary sector, focusing on engine parts. The company reported a market capitalization of ₹9,217 Cr and a share price of ₹644. For the financial year ending March 2025, sales reached ₹3,213 Cr, reflecting a significant increase from ₹2,332 Cr in the previous year. The sales growth trajectory has been robust, with quarterly sales rising from ₹628 Cr in September 2022 to ₹895 Cr by September 2024. This upward trend indicates a rising demand for the company’s products, bolstered by a recovery in the automotive sector post-pandemic. The operating profit margin (OPM) stood at 19% for the year ending March 2025, up from 16% the previous year, showcasing enhanced operational efficiency. The company has consistently improved its revenue from operations, with a trailing twelve months (TTM) revenue of ₹3,522 Cr, indicating a healthy growth path. This aligns with industry trends where a recovery in vehicle sales and production has been observed, providing a favorable backdrop for companies in this segment.
Profitability and Efficiency Metrics
Banco Products recorded a net profit of ₹392 Cr for the financial year ending March 2025, up from ₹236 Cr in March 2023, highlighting a significant improvement in profitability. The company achieved a return on equity (ROE) of 30.08% and a return on capital employed (ROCE) of 32.38%, both of which are considerably higher than typical sector averages, indicating strong management effectiveness and operational efficiency. The interest coverage ratio (ICR) stood at an impressive 25.52x, reflecting the company’s ability to meet interest obligations comfortably. Furthermore, the operating profit for March 2025 reached ₹611 Cr, with an OPM of 19%, showcasing the company’s capacity to maintain profitability amidst rising operational costs. However, the cash conversion cycle (CCC) of 231 days signals potential inefficiencies in working capital management, which could be an area for improvement. Overall, Banco Products has demonstrated strong profitability metrics, positioning itself favorably within the competitive landscape of the auto ancillary industry.
Balance Sheet Strength and Financial Ratios
The balance sheet of Banco Products is characterized by a total debt of ₹729 Cr against total assets of ₹3,078 Cr, resulting in a debt-to-equity ratio of 0.24, which is relatively low and suggests prudent financial management. The company’s reserves increased to ₹1,606 Cr by September 2025, providing a cushion for future investments and growth. Additionally, the current ratio stood at 1.98, indicating strong liquidity and the ability to cover short-term obligations. The price-to-book value (P/BV) ratio was reported at 3.79x, reflecting investor confidence in the company’s growth prospects compared to its book value. The increase in fixed assets to ₹516 Cr indicates ongoing investments in capacity and infrastructure, essential for sustaining growth. However, the rising trend in borrowings, which increased from ₹418 Cr in March 2023 to ₹729 Cr by September 2025, poses a risk if not managed effectively. Overall, Banco Products’ balance sheet exhibits resilience and a solid foundation for future growth.
Shareholding Pattern and Investor Confidence
Banco Products has a stable shareholding structure, with promoters holding 67.88% of the equity, indicating strong control and commitment to the company. The foreign institutional investors (FIIs) have increased their stake to 4.40% as of September 2025, reflecting growing confidence from external investors. Domestic institutional investors (DIIs) hold a modest 0.29%, while the public holds 27.42% of the shares, suggesting a diversified ownership base. The number of shareholders increased to 72,708 by September 2025, indicating rising interest in the company among retail investors. This growing shareholder base can enhance liquidity and market perception. However, the low DII participation may indicate a lack of institutional confidence relative to peers. The relatively high promoter holding can be a double-edged sword; while it signifies stability, it may also raise concerns about reduced market float. Overall, the shareholding pattern reflects a strong foundational support, but also highlights areas for potential improvement in institutional engagement.
Outlook, Risks, and Final Insight
Looking ahead, Banco Products is well-positioned to benefit from the ongoing recovery in the automotive sector, supported by its strong revenue growth and profitability metrics. The company’s focus on enhancing operational efficiencies could further improve its margins. However, risks remain, particularly related to rising borrowings which could pressure financial stability if not managed prudently. Additionally, the company may face challenges related to supply chain disruptions and fluctuating raw material costs, which could impact profitability. The cash conversion cycle indicates potential inefficiencies that, if addressed, could unlock further value. In summary, while Banco Products demonstrates strong fundamentals and growth potential, careful management of its debt levels and operational efficiencies will be crucial to sustaining its growth trajectory and shareholder value in the competitive auto ancillary landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IP Rings Ltd | 127 Cr. | 101 | 188/99.0 | 80.2 | 0.00 % | 3.08 % | 4.14 % | 10.0 | |
| Talbros Automotive Components Ltd | 1,679 Cr. | 272 | 326/200 | 17.6 | 110 | 0.26 % | 19.3 % | 15.9 % | 2.00 |
| Sundram Fasteners Ltd | 19,608 Cr. | 933 | 1,132/831 | 35.4 | 193 | 0.77 % | 17.1 % | 14.9 % | 1.00 |
| Sintercom India Ltd | 267 Cr. | 97.0 | 164/93.2 | 267 | 37.1 | 0.00 % | 5.08 % | 0.66 % | 10.0 |
| Shriram Pistons & Rings Ltd | 12,712 Cr. | 2,886 | 3,416/1,556 | 23.5 | 599 | 0.35 % | 25.7 % | 23.2 % | 10.0 |
| Industry Average | 13,070.17 Cr | 3,585.87 | 51.69 | 554.76 | 0.67% | 16.53% | 14.30% | 7.25 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 628 | 509 | 609 | 749 | 725 | 571 | 724 | 804 | 895 | 639 | 875 | 970 | 1,038 |
| Expenses | 569 | 369 | 511 | 653 | 602 | 482 | 610 | 671 | 689 | 581 | 660 | 788 | 889 |
| Operating Profit | 59 | 140 | 98 | 97 | 122 | 89 | 114 | 133 | 206 | 58 | 214 | 182 | 149 |
| OPM % | 9% | 28% | 16% | 13% | 17% | 16% | 16% | 17% | 23% | 9% | 24% | 19% | 14% |
| Other Income | 10 | 1 | 3 | 16 | 3 | 12 | 6 | 2 | 17 | 5 | 19 | 14 | 59 |
| Interest | 1 | 3 | 7 | 5 | 6 | 4 | 7 | 7 | 6 | 5 | 8 | 7 | 8 |
| Depreciation | 12 | 13 | 20 | 15 | 16 | 17 | 28 | 19 | 19 | 20 | 36 | 24 | 25 |
| Profit before tax | 56 | 126 | 74 | 93 | 104 | 81 | 86 | 109 | 197 | 39 | 190 | 164 | 175 |
| Tax % | 8% | 22% | 31% | 26% | 36% | 15% | 20% | 37% | 30% | 21% | 19% | 33% | 20% |
| Net Profit | 52 | 98 | 51 | 69 | 66 | 68 | 68 | 69 | 139 | 31 | 154 | 110 | 139 |
| EPS in Rs | 3.62 | 6.87 | 3.57 | 4.81 | 4.62 | 4.78 | 4.77 | 4.80 | 9.70 | 2.16 | 10.73 | 7.66 | 9.71 |
Last Updated: January 2, 2026, 8:01 am
Below is a detailed analysis of the quarterly data for Banco Products (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,038.00 Cr.. The value appears strong and on an upward trend. It has increased from 970.00 Cr. (Jun 2025) to 1,038.00 Cr., marking an increase of 68.00 Cr..
- For Expenses, as of Sep 2025, the value is 889.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 788.00 Cr. (Jun 2025) to 889.00 Cr., marking an increase of 101.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 149.00 Cr.. The value appears to be declining and may need further review. It has decreased from 182.00 Cr. (Jun 2025) to 149.00 Cr., marking a decrease of 33.00 Cr..
- For OPM %, as of Sep 2025, the value is 14.00%. The value appears to be declining and may need further review. It has decreased from 19.00% (Jun 2025) to 14.00%, marking a decrease of 5.00%.
- For Other Income, as of Sep 2025, the value is 59.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Jun 2025) to 59.00 Cr., marking an increase of 45.00 Cr..
- For Interest, as of Sep 2025, the value is 8.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.00 Cr. (Jun 2025) to 8.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 25.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 24.00 Cr. (Jun 2025) to 25.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 175.00 Cr.. The value appears strong and on an upward trend. It has increased from 164.00 Cr. (Jun 2025) to 175.00 Cr., marking an increase of 11.00 Cr..
- For Tax %, as of Sep 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 33.00% (Jun 2025) to 20.00%, marking a decrease of 13.00%.
- For Net Profit, as of Sep 2025, the value is 139.00 Cr.. The value appears strong and on an upward trend. It has increased from 110.00 Cr. (Jun 2025) to 139.00 Cr., marking an increase of 29.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 9.71. The value appears strong and on an upward trend. It has increased from 7.66 (Jun 2025) to 9.71, marking an increase of 2.05.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:35 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,116 | 1,129 | 1,148 | 1,239 | 1,336 | 1,567 | 1,422 | 1,533 | 1,958 | 2,332 | 2,768 | 3,213 | 3,522 |
| Expenses | 951 | 1,027 | 1,002 | 1,096 | 1,157 | 1,405 | 1,300 | 1,354 | 1,686 | 1,966 | 2,340 | 2,601 | 2,918 |
| Operating Profit | 165 | 102 | 146 | 144 | 179 | 161 | 122 | 178 | 272 | 366 | 428 | 611 | 604 |
| OPM % | 15% | 9% | 13% | 12% | 13% | 10% | 9% | 12% | 14% | 16% | 15% | 19% | 17% |
| Other Income | 9 | 53 | 11 | 32 | 18 | 10 | 25 | 9 | 5 | 14 | 32 | 43 | 96 |
| Interest | 19 | 8 | 3 | 2 | 2 | 4 | 3 | 4 | 5 | 13 | 21 | 26 | 28 |
| Depreciation | 32 | 34 | 35 | 33 | 28 | 29 | 33 | 34 | 48 | 56 | 76 | 94 | 105 |
| Profit before tax | 122 | 113 | 119 | 141 | 167 | 138 | 111 | 150 | 224 | 311 | 363 | 534 | 568 |
| Tax % | 26% | 22% | 25% | 31% | 30% | 50% | 31% | 24% | 32% | 24% | 25% | 27% | |
| Net Profit | 90 | 88 | 90 | 97 | 117 | 69 | 77 | 114 | 152 | 236 | 271 | 392 | 433 |
| EPS in Rs | 6.28 | 6.13 | 6.29 | 6.80 | 8.17 | 4.83 | 5.36 | 7.95 | 10.66 | 16.47 | 18.98 | 27.39 | 30.26 |
| Dividend Payout % | 16% | 24% | 37% | 66% | 61% | 83% | 187% | 13% | 94% | 67% | 53% | 40% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -2.22% | 2.27% | 7.78% | 20.62% | -41.03% | 11.59% | 48.05% | 33.33% | 55.26% | 14.83% | 44.65% |
| Change in YoY Net Profit Growth (%) | 0.00% | 4.49% | 5.51% | 12.84% | -61.64% | 52.62% | 36.46% | -14.72% | 21.93% | -40.43% | 29.82% |
Banco Products (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 39% |
| 3 Years: | 36% |
| TTM: | 60% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 67% |
| 3 Years: | 68% |
| 1 Year: | 80% |
| Return on Equity | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 24% |
| 3 Years: | 28% |
| Last Year: | 32% |
Last Updated: September 5, 2025, 12:30 am
Balance Sheet
Last Updated: December 4, 2025, 1:01 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 29 | 29 |
| Reserves | 574 | 605 | 674 | 705 | 793 | 818 | 696 | 814 | 967 | 987 | 1,037 | 1,274 | 1,606 |
| Borrowings | 172 | 36 | 36 | 38 | 34 | 40 | 92 | 14 | 115 | 418 | 423 | 573 | 729 |
| Other Liabilities | 183 | 164 | 232 | 211 | 356 | 322 | 287 | 344 | 405 | 435 | 508 | 868 | 714 |
| Total Liabilities | 944 | 819 | 956 | 969 | 1,197 | 1,195 | 1,089 | 1,187 | 1,502 | 1,855 | 1,982 | 2,744 | 3,078 |
| Fixed Assets | 243 | 227 | 221 | 192 | 191 | 184 | 193 | 190 | 297 | 359 | 454 | 516 | 484 |
| CWIP | 12 | 11 | 3 | 4 | 13 | 13 | 3 | 1 | 15 | 18 | 10 | 5 | 16 |
| Investments | 71 | 1 | 1 | 91 | 24 | 69 | 9 | 1 | 1 | 0 | 0 | 38 | 76 |
| Other Assets | 618 | 581 | 731 | 682 | 969 | 929 | 883 | 995 | 1,190 | 1,477 | 1,518 | 2,185 | 2,501 |
| Total Assets | 944 | 819 | 956 | 969 | 1,197 | 1,195 | 1,089 | 1,187 | 1,502 | 1,855 | 1,982 | 2,744 | 3,078 |
Below is a detailed analysis of the balance sheet data for Banco Products (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 29.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 29.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,606.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,274.00 Cr. (Mar 2025) to 1,606.00 Cr., marking an increase of 332.00 Cr..
- For Borrowings, as of Sep 2025, the value is 729.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 573.00 Cr. (Mar 2025) to 729.00 Cr., marking an increase of 156.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 714.00 Cr.. The value appears to be improving (decreasing). It has decreased from 868.00 Cr. (Mar 2025) to 714.00 Cr., marking a decrease of 154.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,078.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,744.00 Cr. (Mar 2025) to 3,078.00 Cr., marking an increase of 334.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 484.00 Cr.. The value appears to be declining and may need further review. It has decreased from 516.00 Cr. (Mar 2025) to 484.00 Cr., marking a decrease of 32.00 Cr..
- For CWIP, as of Sep 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2025) to 16.00 Cr., marking an increase of 11.00 Cr..
- For Investments, as of Sep 2025, the value is 76.00 Cr.. The value appears strong and on an upward trend. It has increased from 38.00 Cr. (Mar 2025) to 76.00 Cr., marking an increase of 38.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,501.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,185.00 Cr. (Mar 2025) to 2,501.00 Cr., marking an increase of 316.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,078.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,744.00 Cr. (Mar 2025) to 3,078.00 Cr., marking an increase of 334.00 Cr..
Notably, the Reserves (1,606.00 Cr.) exceed the Borrowings (729.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -7.00 | 66.00 | 110.00 | 106.00 | 145.00 | 121.00 | 30.00 | 164.00 | 157.00 | -52.00 | 5.00 | 38.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 70 | 57 | 70 | 60 | 70 | 63 | 75 | 64 | 60 | 65 | 63 | 69 |
| Inventory Days | 172 | 152 | 190 | 171 | 217 | 191 | 212 | 234 | 225 | 271 | 210 | 289 |
| Days Payable | 57 | 39 | 71 | 51 | 90 | 102 | 99 | 118 | 95 | 95 | 90 | 128 |
| Cash Conversion Cycle | 184 | 170 | 189 | 180 | 197 | 152 | 188 | 180 | 191 | 241 | 183 | 231 |
| Working Capital Days | 71 | 103 | 107 | 105 | 108 | 111 | 120 | 132 | 133 | 123 | 102 | 106 |
| ROCE % | 19% | 12% | 18% | 17% | 21% | 17% | 13% | 19% | 24% | 26% | 27% | 32% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 27.39 | 37.95 | 32.94 | 21.31 | 15.90 |
| Diluted EPS (Rs.) | 27.39 | 37.95 | 32.94 | 21.31 | 15.90 |
| Cash EPS (Rs.) | 33.99 | 48.57 | 40.82 | 28.00 | 20.61 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.05 | 146.95 | 139.96 | 137.19 | 115.76 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.08 | 147.03 | 140.03 | 137.27 | 115.83 |
| Revenue From Operations / Share (Rs.) | 224.59 | 387.09 | 326.04 | 273.78 | 214.29 |
| PBDIT / Share (Rs.) | 45.74 | 64.33 | 53.10 | 38.72 | 26.17 |
| PBIT / Share (Rs.) | 39.14 | 53.70 | 45.22 | 32.02 | 21.46 |
| PBT / Share (Rs.) | 37.35 | 50.71 | 43.46 | 31.29 | 20.95 |
| Net Profit / Share (Rs.) | 27.39 | 37.95 | 32.94 | 21.31 | 15.90 |
| NP After MI And SOA / Share (Rs.) | 27.39 | 37.95 | 32.94 | 21.31 | 15.90 |
| PBDIT Margin (%) | 20.36 | 16.61 | 16.28 | 14.14 | 12.21 |
| PBIT Margin (%) | 17.42 | 13.87 | 13.86 | 11.69 | 10.01 |
| PBT Margin (%) | 16.62 | 13.10 | 13.32 | 11.42 | 9.77 |
| Net Profit Margin (%) | 12.19 | 9.80 | 10.10 | 7.78 | 7.42 |
| NP After MI And SOA Margin (%) | 12.19 | 9.80 | 10.10 | 7.78 | 7.42 |
| Return on Networth / Equity (%) | 30.08 | 25.82 | 23.53 | 15.53 | 13.73 |
| Return on Capital Employeed (%) | 32.38 | 28.32 | 26.21 | 19.63 | 16.89 |
| Return On Assets (%) | 13.76 | 13.38 | 12.50 | 9.95 | 9.35 |
| Long Term Debt / Equity (X) | 0.01 | 0.03 | 0.03 | 0.01 | 0.01 |
| Total Debt / Equity (X) | 0.24 | 0.21 | 0.29 | 0.02 | 0.01 |
| Asset Turnover Ratio (%) | 1.32 | 1.42 | 0.84 | 0.79 | 0.70 |
| Current Ratio (X) | 1.98 | 2.24 | 2.24 | 3.17 | 3.21 |
| Quick Ratio (X) | 0.74 | 0.86 | 0.70 | 1.20 | 1.37 |
| Inventory Turnover Ratio (X) | 2.79 | 1.59 | 1.31 | 1.39 | 1.21 |
| Dividend Payout Ratio (NP) (%) | 40.15 | 89.59 | 24.28 | 9.38 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 32.36 | 69.99 | 19.59 | 7.14 | 0.00 |
| Earning Retention Ratio (%) | 59.85 | 10.41 | 75.72 | 90.62 | 0.00 |
| Cash Earning Retention Ratio (%) | 67.64 | 30.01 | 80.41 | 92.86 | 0.00 |
| Interest Coverage Ratio (X) | 25.52 | 21.54 | 30.18 | 52.69 | 51.73 |
| Interest Coverage Ratio (Post Tax) (X) | 16.29 | 13.70 | 19.72 | 30.00 | 32.44 |
| Enterprise Value (Cr.) | 5131.35 | 4411.67 | 1882.76 | 913.42 | 896.66 |
| EV / Net Operating Revenue (X) | 1.60 | 1.59 | 0.80 | 0.46 | 0.58 |
| EV / EBITDA (X) | 7.84 | 9.59 | 4.96 | 3.30 | 4.79 |
| MarketCap / Net Operating Revenue (X) | 1.54 | 1.54 | 0.69 | 0.49 | 0.65 |
| Retention Ratios (%) | 59.84 | 10.40 | 75.71 | 90.61 | 0.00 |
| Price / BV (X) | 3.79 | 4.05 | 1.61 | 0.99 | 1.21 |
| Price / Net Operating Revenue (X) | 1.54 | 1.54 | 0.69 | 0.49 | 0.65 |
| EarningsYield | 0.07 | 0.06 | 0.14 | 0.15 | 0.11 |
After reviewing the key financial ratios for Banco Products (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 27.39. This value is within the healthy range. It has decreased from 37.95 (Mar 24) to 27.39, marking a decrease of 10.56.
- For Diluted EPS (Rs.), as of Mar 25, the value is 27.39. This value is within the healthy range. It has decreased from 37.95 (Mar 24) to 27.39, marking a decrease of 10.56.
- For Cash EPS (Rs.), as of Mar 25, the value is 33.99. This value is within the healthy range. It has decreased from 48.57 (Mar 24) to 33.99, marking a decrease of 14.58.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.05. It has decreased from 146.95 (Mar 24) to 91.05, marking a decrease of 55.90.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.08. It has decreased from 147.03 (Mar 24) to 91.08, marking a decrease of 55.95.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 224.59. It has decreased from 387.09 (Mar 24) to 224.59, marking a decrease of 162.50.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 45.74. This value is within the healthy range. It has decreased from 64.33 (Mar 24) to 45.74, marking a decrease of 18.59.
- For PBIT / Share (Rs.), as of Mar 25, the value is 39.14. This value is within the healthy range. It has decreased from 53.70 (Mar 24) to 39.14, marking a decrease of 14.56.
- For PBT / Share (Rs.), as of Mar 25, the value is 37.35. This value is within the healthy range. It has decreased from 50.71 (Mar 24) to 37.35, marking a decrease of 13.36.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 27.39. This value is within the healthy range. It has decreased from 37.95 (Mar 24) to 27.39, marking a decrease of 10.56.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 27.39. This value is within the healthy range. It has decreased from 37.95 (Mar 24) to 27.39, marking a decrease of 10.56.
- For PBDIT Margin (%), as of Mar 25, the value is 20.36. This value is within the healthy range. It has increased from 16.61 (Mar 24) to 20.36, marking an increase of 3.75.
- For PBIT Margin (%), as of Mar 25, the value is 17.42. This value is within the healthy range. It has increased from 13.87 (Mar 24) to 17.42, marking an increase of 3.55.
- For PBT Margin (%), as of Mar 25, the value is 16.62. This value is within the healthy range. It has increased from 13.10 (Mar 24) to 16.62, marking an increase of 3.52.
- For Net Profit Margin (%), as of Mar 25, the value is 12.19. This value exceeds the healthy maximum of 10. It has increased from 9.80 (Mar 24) to 12.19, marking an increase of 2.39.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.19. This value is within the healthy range. It has increased from 9.80 (Mar 24) to 12.19, marking an increase of 2.39.
- For Return on Networth / Equity (%), as of Mar 25, the value is 30.08. This value is within the healthy range. It has increased from 25.82 (Mar 24) to 30.08, marking an increase of 4.26.
- For Return on Capital Employeed (%), as of Mar 25, the value is 32.38. This value is within the healthy range. It has increased from 28.32 (Mar 24) to 32.38, marking an increase of 4.06.
- For Return On Assets (%), as of Mar 25, the value is 13.76. This value is within the healthy range. It has increased from 13.38 (Mar 24) to 13.76, marking an increase of 0.38.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.24. This value is within the healthy range. It has increased from 0.21 (Mar 24) to 0.24, marking an increase of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.32. It has decreased from 1.42 (Mar 24) to 1.32, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 1.98. This value is within the healthy range. It has decreased from 2.24 (Mar 24) to 1.98, marking a decrease of 0.26.
- For Quick Ratio (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 0.86 (Mar 24) to 0.74, marking a decrease of 0.12.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.79. This value is below the healthy minimum of 4. It has increased from 1.59 (Mar 24) to 2.79, marking an increase of 1.20.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 40.15. This value is within the healthy range. It has decreased from 89.59 (Mar 24) to 40.15, marking a decrease of 49.44.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 32.36. This value is within the healthy range. It has decreased from 69.99 (Mar 24) to 32.36, marking a decrease of 37.63.
- For Earning Retention Ratio (%), as of Mar 25, the value is 59.85. This value is within the healthy range. It has increased from 10.41 (Mar 24) to 59.85, marking an increase of 49.44.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 67.64. This value is within the healthy range. It has increased from 30.01 (Mar 24) to 67.64, marking an increase of 37.63.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 25.52. This value is within the healthy range. It has increased from 21.54 (Mar 24) to 25.52, marking an increase of 3.98.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 16.29. This value is within the healthy range. It has increased from 13.70 (Mar 24) to 16.29, marking an increase of 2.59.
- For Enterprise Value (Cr.), as of Mar 25, the value is 5,131.35. It has increased from 4,411.67 (Mar 24) to 5,131.35, marking an increase of 719.68.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has increased from 1.59 (Mar 24) to 1.60, marking an increase of 0.01.
- For EV / EBITDA (X), as of Mar 25, the value is 7.84. This value is within the healthy range. It has decreased from 9.59 (Mar 24) to 7.84, marking a decrease of 1.75.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.54. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.54.
- For Retention Ratios (%), as of Mar 25, the value is 59.84. This value is within the healthy range. It has increased from 10.40 (Mar 24) to 59.84, marking an increase of 49.44.
- For Price / BV (X), as of Mar 25, the value is 3.79. This value exceeds the healthy maximum of 3. It has decreased from 4.05 (Mar 24) to 3.79, marking a decrease of 0.26.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.54. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.54.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Banco Products (India) Ltd:
- Net Profit Margin: 12.19%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 32.38% (Industry Average ROCE: 16.53%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 30.08% (Industry Average ROE: 14.3%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 16.29
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.74
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 20.8 (Industry average Stock P/E: 51.69)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.24
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.19%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Auto Ancl - Engine Parts | Bil, Near Bhaili Railway Station, Vadodra District Gujarat 391410 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mehul K Patel | Chairman |
| Mr. Venkata Ranganath Kumar Sami | Whole Time Director |
| Mr. Sharan M Patel | Whole Time Director |
| Mr. Shivam M Patel | Non Executive Director |
| Ms. Ameeta V Manohar | Independent Director |
| Mr. Tarak A Patel | Independent Director |
| Mr. Anand A Majmudar | Independent Director |
| Mr. Pranav R Patel | Independent Director |
FAQ
What is the intrinsic value of Banco Products (India) Ltd?
Banco Products (India) Ltd's intrinsic value (as of 18 January 2026) is ₹765.72 which is 21.54% higher the current market price of ₹630.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹9,012 Cr. market cap, FY2025-2026 high/low of ₹880/293, reserves of ₹1,606 Cr, and liabilities of ₹3,078 Cr.
What is the Market Cap of Banco Products (India) Ltd?
The Market Cap of Banco Products (India) Ltd is 9,012 Cr..
What is the current Stock Price of Banco Products (India) Ltd as on 18 January 2026?
The current stock price of Banco Products (India) Ltd as on 18 January 2026 is ₹630.
What is the High / Low of Banco Products (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Banco Products (India) Ltd stocks is ₹880/293.
What is the Stock P/E of Banco Products (India) Ltd?
The Stock P/E of Banco Products (India) Ltd is 20.8.
What is the Book Value of Banco Products (India) Ltd?
The Book Value of Banco Products (India) Ltd is 114.
What is the Dividend Yield of Banco Products (India) Ltd?
The Dividend Yield of Banco Products (India) Ltd is 1.75 %.
What is the ROCE of Banco Products (India) Ltd?
The ROCE of Banco Products (India) Ltd is 32.4 %.
What is the ROE of Banco Products (India) Ltd?
The ROE of Banco Products (India) Ltd is 32.2 %.
What is the Face Value of Banco Products (India) Ltd?
The Face Value of Banco Products (India) Ltd is 2.00.